RUI: Targeting the Terminus for Site-Specific Recognition and Labeling of Proteins
RUI:针对蛋白质位点特异性识别和标记的终点
基本信息
- 批准号:1309978
- 负责人:
- 金额:$ 33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Continuing Grant
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In this project funded by the Macromolecular, Supramolecular and Nanochemistry Program of the Chemistry Division, Adam Urbach of Trinity University explores the hypothesis that the terminus of a polypeptide chain has unique structural and conformational properties that may provide a general approach to protein recognition that is specific to a single site and is predictable both from the sequence of amino acids and from the receptor's ability to recognize short peptides of the same sequence. The project has three complementary aims. The first aim focuses on the discovery and characterization of new motifs for the recognition of peptide termini by synthetic receptors. The second part asks whether these receptors can recognize proteins containing the same terminal sequences. The third part involves the application of the recognition work to the labeling, capture, and release of proteins using conjugates of the synthetic receptors to bring functionality to the terminus of the proteins targeted in these studies. In addition to the societal benefits of being able to identify, isolate, and label specific proteins, the broader impacts involve intense training of undergraduate students in the research laboratory and a plan for the training of postdoctoral scholars that addresses crucial aspects of professional development in scholarship, teaching, and service in order to best prepare them to begin a career at a primarily undergraduate institution.The ability to distinguish between the numerous proteins in living systems is crucial to biological and biotechnological processes, but currently only antibodies can do this reliably and antibody-based technology can be very costly. This research aims to address this problem by developing new methods for interacting with proteins using synthetic receptors, which can be much less expensive and easier to modify. The focus of this project is to explore the recently developed concept that the very end of a protein chain (the terminus) is an ideal site for interacting with a receptor because the tail, like the end of a ball of string, can easily unravel. If successful, this research would establish a general method for predictably interacting with proteins, and it would form the foundation for developing tools that substantially improve our understanding of protein function in living systems.
在化学系高分子、超分子和纳米化学项目资助的这个项目中,三一大学(Trinity University)的Adam Urbach探索了这样一种假设:多肽链末端具有独特的结构和构象特性,这可能提供一种蛋白质识别的通用方法,该方法对单个位点具有特异性,并且可以从氨基酸序列和受体识别能力来预测相同序列的短肽。该项目有三个相辅相成的目标。第一个目标集中在发现和表征新的图案识别肽末端的合成受体。第二部分探讨这些受体是否能够识别含有相同末端序列的蛋白质。第三部分涉及识别工作的应用,以标记,捕获和释放的蛋白质,使用合成受体的缀合物,使功能的蛋白质在这些研究中的目标的末端。除了能够识别,分离和标记特定蛋白质的社会效益外,更广泛的影响还包括在研究实验室对本科生进行密集培训,以及培养博士后学者的计划,该计划涉及学术,教学,区分生命系统中众多蛋白质的能力对生物学和生物学的发展至关重要,生物技术过程,但目前只有抗体可以做到这一点可靠和抗体为基础的技术可能是非常昂贵的。这项研究旨在通过开发使用合成受体与蛋白质相互作用的新方法来解决这个问题,这种方法可以更便宜,更容易修改。该项目的重点是探索最近发展的概念,即蛋白质链的末端(末端)是与受体相互作用的理想场所,因为尾巴就像一个线团的末端,可以很容易地解开。如果成功,这项研究将建立一种可预测的与蛋白质相互作用的通用方法,并将为开发工具奠定基础,从而大大提高我们对生命系统中蛋白质功能的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam Urbach其他文献
Adam Urbach的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam Urbach', 18)}}的其他基金
MRI: Acquisition of an ESI-TOF Mass Spectrometer by Trinity University
MRI:三一大学购买 ESI-TOF 质谱仪
- 批准号:
1726441 - 财政年份:2017
- 资助金额:
$ 33万 - 项目类别:
Standard Grant
CAREER: Synthetic Co-Hosts for Sequence-Specific Recognition and Labeling of Peptides in Aqueous Solution
职业:用于水溶液中肽的序列特异性识别和标记的合成共宿主
- 批准号:
0748483 - 财政年份:2008
- 资助金额:
$ 33万 - 项目类别:
Continuing Grant
Acquisition of a Circular Dichroism Spectropolarimeter with Stopped-Flow Detection for Undergraduate Research
为本科生研究购买具有停流检测功能的圆二色性分光光度计
- 批准号:
0718766 - 财政年份:2007
- 资助金额:
$ 33万 - 项目类别:
Standard Grant
相似国自然基金
Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
- 批准号:81873493
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Fragment to small molecule hit discovery targeting Mycobacterium tuberculosis FtsZ
针对结核分枝杆菌 FtsZ 的小分子片段发现
- 批准号:
MR/Z503757/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
Targeting metabolism to improve the host response to peritoneal dialysis
靶向代谢以改善宿主对腹膜透析的反应
- 批准号:
MR/Y013816/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
Targeting Inhibitory kappa B kinase alpha (IKKalpha): a new treatment paradigm for inflammatory-driven cancers
靶向抑制性 kappa B 激酶 alpha (IKKalpha):炎症驱动的癌症的新治疗范例
- 批准号:
MR/Y015479/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
Development of a novel cancer immunotherapy model targeting human macrophages
开发针对人类巨噬细胞的新型癌症免疫治疗模型
- 批准号:
24K18516 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Genetic targeting of a synthetic dye for voltage imaging of cerebellar Purkinje neurons during a tongue grasping task
一种合成染料的基因靶向,用于抓取舌头任务期间小脑浦肯野神经元的电压成像
- 批准号:
23K27147 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimisation of small molecule inhibitors for effective targeting of phospholipase C gamma in T-cell lymphoma
优化小分子抑制剂以有效靶向 T 细胞淋巴瘤中的磷脂酶 C γ
- 批准号:
MR/Y503344/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
Targeting soluble guanylate cyclase as a novel strategy to treat and prevent cardiac arrhythmias: efficacy and mechanisms
靶向可溶性鸟苷酸环化酶作为治疗和预防心律失常的新策略:功效和机制
- 批准号:
MR/Y003594/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
Targeting axonal transport regulation by neurotrophic factors to treat peripheral nerve degeneration
通过神经营养因子调节轴突运输来治疗周围神经变性
- 批准号:
MR/Y010949/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Fellowship
Reducing organ fibrosis by targeting a novel pro-fibrotic CLEC4D expressing myeloid subset.
通过靶向表达新型促纤维化 CLEC4D 的骨髓亚群来减少器官纤维化。
- 批准号:
MR/Y014103/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant